Wataru Tomeno Selected Research

Wataru Tomeno Research Topics

Disease

24	Non-alcoholic Fatty Liver Disease 03/2023 - 10/2009
7	Fibrosis (Cirrhosis) 10/2018 - 10/2009
6	Inflammation (Inflammations) 01/2022 - 01/2012
5	Liver Cirrhosis (Hepatic Cirrhosis) 03/2023 - 01/2018
3	Insulin Resistance 10/2021 - 01/2016
3	Obesity 10/2021 - 01/2016
3	Liver Diseases (Liver Disease) 10/2021 - 01/2017
2	Neoplasms (Cancer) 11/2020 - 07/2013
2	Constipation 11/2020 - 01/2018
2	Alcoholic Fatty Liver 01/2014 - 10/2009
1	Hypothyroidism 11/2020
1	Obstructive Sleep Apnea 11/2020
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2020
1	Periodontitis 11/2020
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Gastroesophageal Reflux (GERD) 11/2020
1	Chronic Renal Insufficiency 11/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2018
1	Poisoning 08/2017
1	Hepatitis C 11/2013
1	Stomach Neoplasms (Stomach Cancer) 07/2013
1	Hepatocellular Carcinoma (Hepatoma) 03/2013
1	Hypertension (High Blood Pressure) 01/2012
1	Body Weight (Weight, Body) 01/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2012

Drug/Important Bio-Agent (IBA)

4	Therapeutic UsesIBA 08/2017 - 07/2012
3	Collagen Type IV (Type IV Collagen)IBA 03/2023 - 12/2017
3	Messenger RNA (mRNA)IBA 10/2021 - 10/2009
3	Alanine Transaminase (SGPT)IBA 11/2020 - 03/2016
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2014
2	Lubiprostone FDA Link 11/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 07/2013
2	Nonesterified Fatty Acids (NEFA)IBA 01/2018 - 01/2016
2	RNA (Ribonucleic Acid)IBA 12/2017 - 03/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017 - 01/2012
2	LipopolysaccharidesIBA 02/2016 - 01/2013
2	LipidsIBA 01/2016 - 01/2014
1	IronIBA 01/2022
1	SGL5213IBA 10/2021
1	Sucrose (Saccharose)IBA 10/2021
1	Sodium-Glucose Transporter 1IBA 10/2021
1	miglitol (Glyset)FDA Link 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	GlucosidasesIBA 10/2021
1	Growth Hormone (Somatotropin)IBA 11/2020
1	EnzymesIBA 11/2020
1	Protons (Proton)IBA 11/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 08/2020
1	wisteria lectinIBA 10/2018
1	Carrier Proteins (Binding Protein)IBA 10/2018
1	Oxidoreductases (Dehydrogenase)IBA 02/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	EndotoxinsIBA 01/2018
1	PalmitatesIBA 01/2018
1	Chloride Channels (Chloride Channel)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	LaxativesIBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 08/2017
1	AntioxidantsIBA 08/2017
1	Fibric Acids (Fibrates)IBA 01/2017
1	Fenofibrate (CiL)FDA LinkGeneric 01/2017
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 01/2017
1	PPAR alphaIBA 01/2017
1	Phospholipases (Phospholipase)IBA 09/2016
1	Keratin-18 (Keratin 18)IBA 03/2016
1	ResveratrolIBA 02/2016
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2016
1	ipragliflozinIBA 01/2016
1	Islet Amyloid PolypeptideIBA 01/2016
1	Transaminases (Aminotransferases)IBA 06/2015
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 06/2015
1	Ferritins (Ferritin)IBA 06/2015
1	Choline (Choline Chloride)IBA 02/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014
1	oxidized low density lipoproteinIBA 01/2014
1	Lipase (Acid Lipase)FDA Link 11/2013
1	Capecitabine (Xeloda)FDA Link 07/2013
1	Trastuzumab (Herceptin)FDA Link 07/2013
1	Cisplatin (Platino)FDA LinkGeneric 07/2013
1	Lipopolysaccharide ReceptorsIBA 01/2013
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2012
1	Sitagliptin Phosphate (Januvia)FDA Link 07/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2009
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2009

Therapy/Procedure

1	Intravenous Injections 08/2017
1	Oral Administration 08/2017
1	Therapeutics 06/2015
1	Drug Therapy (Chemotherapy) 07/2013
1	Glycemic Control 07/2012